Following a comprehensive strategic review and in consideration of the current regional circumstances, the organizers of Pharmex Middle East have officially announced the rescheduling of the event to September 8–10, 2026.
This decision has been made with the objective of ensuring the highest level of international participation and maximizing the effectiveness of the event for exhibitors, international companies, ambassadors, trade delegations, industry leaders, and professional visitors from across the pharmaceutical and healthcare sectors.
The new dates will provide a stronger platform for international business engagement, high-level networking, technology exchange, and the development of cross-border collaborations within the pharmaceutical value chain.
The Pharmex Secretariat remains fully committed to delivering a high-quality, impactful, and future-oriented event that reflects the evolving needs of the pharmaceutical industry during a period of significant regional and global transformation.
Pharmex Middle East 2026 will continue its mission as a leading platform for pharmaceutical ingredients, manufacturing technologies, packaging, biotechnology, innovation, investment opportunities, and strategic dialogue within the regional pharmaceutical ecosystem.